Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) was down 1.5% during trading on Thursday . The company traded as low as $8.58 and last traded at $8.62. Approximately 34,054 shares traded hands during mid-day trading, a decline of 35% from the average daily volume of 52,536 shares. The stock had previously closed at $8.75.
Analyst Ratings Changes
Separately, Citigroup raised shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a research report on Friday, October 25th.
Read Our Latest Report on FSNUY
Fresenius SE & Co. KGaA Price Performance
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Read More
- Five stocks we like better than Fresenius SE & Co. KGaA
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Legacy Tech Companies Reemerging as AI Leaders
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.